Careers | Site Map | Newsletter | News | Regulatory/Compliance | Privacy | Terms of Use
©2009–2010 SonoSite, Inc. All rights reserved.
Find us on: 
Posted September 2nd, 2010 in Press Releases
BOTHELL, WA – September 2, 2010 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, SonoSite’s President and CEO, will present at the Stifel Nicolaus Healthcare Conference being held at the Four Seasons Hotel in Boston from September 15-17, 2010.
The session will be webcast live on Wednesday, September 15 at 11:30 am, Eastern Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
Posted August 26th, 2010 in Press Releases
First Generation Product Provides Unique Tracking and Guidance Technology for PICC Line Procedures
BOTHELL, WA – August 26, 2010 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it received FDA clearance for its innovative LumenVu® Catheter Guidance System. Designed to aid in the placement of peripherally inserted central catheters (PICC), the proprietary LumenVu System combines near-infrared technology with a revolutionary fiber optic stylet, which replaces a traditional guide wire, to allow visualization and real-time tracking of a catheter tip as it advances through a vein.
“Receiving FDA clearance is an important milestone in the strategic development and global commercialization of the LumenVu System and it reinforces our dedication to providing patients with improved safety and health,” said Kevin M. Goodwin, SonoSite’s President and CEO. “We envision this technology ultimately advancing beyond PICC line placements and potentially into a broader range of clinical applications. This clearance also represents a significant step towards the development of a fully integrated line placement imaging solution, which will include ultrasound visualization.”
An estimated 2.5 million PICC line placements were performed in the United States in 20081, making it one of the most rapidly growing applications performed in the hospital setting. Although a common procedure, PICC placements do pose risks and potential complications. A recent University of Pennsylvania Medical Center study found that only 70% of PICC lines are successful on the first attempt2. Catheters are often incorrectly placed and need to be re-inserted or repositioned by the clinician, which results not only in more time and greater expense, but also increases the risk of infections.
The LumenVu System has the potential to mitigate these risks by providing clinicians with the ability to visualize the catheter tip as it travels through the vessel. Healthcare professionals in hospitals or long-term care facilities will be able to track the progression of a catheter with greater confidence and quickly make navigational adjustments, if necessary.
This proprietary solution potentially offers a number of advantages in the PICC marketplace. The LumenVu System is compatible with standard catheter suppliers and is designed to allow clinicians seamless integration of the product into their current PICC line process. Additionally, the LumenVu System does not rely on a magnetic field and will not interfere with medical equipment or with devices in the patient’s body, such as a pacemaker.
Several hospitals in Europe are currently evaluating the LumenVu Catheter Guidance System in their clinical practices.
For more information about the LumenVu System, visit www.sonosite.com/products/lumenvu.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
1Moureau N Vascular Safety: It’s all about PICCs Nursing Management 2006: Volume 37 Number 5 22-27
2Trerotola SO, Thompson S, Chittams J, Vierregger KS Analysis of Tip Malposition and Correction in Peripherally Inserted Central Catheters Placed at Bedside by a Dedicated Nursing Team J Vasc Interv Radiol 2007; 18: 513 – 518
Posted August 12th, 2010 in Press Releases
Mr. Cramer Will Remain on the Board as Chairman Emeritus Through the End of His Term in April 2011
SonoSite’s Board Adopts a Smaller and More Simplified Structure for 2011
BOTHELL, WA – August 12, 2010 – SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that Kirby L. Cramer is retiring as non-executive Chairman of the Board of Directors, effective August 12, 2010. As part of the Board’s succession plan, Mr. Cramer will continue to serve as a director until SonoSite’s 2011 annual meeting of shareholders. SonoSite’s Board is naming Robert G. Hauser, M.D., F.A.C.C., F.H.R.S. to serve as non-executive Chairman of the Board. Mr. Cramer and Dr. Hauser will begin working together to create an orderly transition process over the next several weeks.
TRUSTED ADVISOR FOR TWELVE YEARS
“Since SonoSite opened for business in April 1998, Kirby Cramer has imbued SonoSite with a long-term discipline and persistent strategic opportunism that has led the company to achieve a revenue run rate of over a quarter billion dollars and an installed base of 60,000 systems from a standing start in 1999,” said Kevin M. Goodwin, SonoSite President and CEO. “We simply would not be where we are today without Kirby’s guidance and encouragement. We wish to thank and fully acknowledge his unique contributions over the past twelve years.”
In recognition of Mr. Cramer’s years of service to SonoSite, the Board of Directors conferred upon him the honorary title of Chairman Emeritus to be held during the balance of his term as a director.
YEARS OF LEADERSHIP EXPERIENCE
Dr. Hauser has served as a member of SonoSite’s Board of Directors since February 2004. Dr. Hauser has been a Senior Consulting Cardiologist at the Minneapolis Heart Institute since 1992. In 2003-2004 and in 1995-1996, he served as President of the Cardiovascular Services Division of Abbott Northwestern Hospital. From 1987 to 2003, he was the Director of the Pacemaker Surveillance Clinic, Minneapolis Heart Institute. From 1988 to 1992, Dr. Hauser served as President and Chief Executive Officer of Cardiac Pacemakers, Inc., a division of Eli Lilly and Company, prior to its merger with Guidant, Inc. Dr. Hauser is a fellow of the American College of Cardiology and a Founder, Past-President and Fellow of the Heart Rhythm Society. He received a bachelor’s degree from the University of Cincinnati and graduated with honors from the College of Medicine at the University of Cincinnati in 1968.
Mr. Goodwin continued, “Dr. Hauser is a great visionary who offers SonoSite a unique set of skills as we move forward into healthcare reform and as the global adoption of our visualization tools continues around the world.”
STRUCTURE CHANGES FOR 2011
With the retirement of Mr. Cramer, following the annual shareholders meeting in April 2011, the Board will have adopted a reduced structure and simplified committee format that will move the company from nine to seven independent members. Additionally, steps have already been taken to reduce the number of committees from five to three (Audit, Compensation, and Nominating and Corporate Governance). The structure is consistent with Nasdaq standards and SEC requirements.
“The cumulative effect of these changes will result in a more streamlined and cost effective structure that will continue to support SonoSite’s corporate governance and strategic oversight responsibilities,” said Carmen Diersen, the company’s Chair of its Corporate Governance Committee.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
Posted August 11th, 2010 in Press Releases
UC Irvine Leadership Takes Medical Education to the Next Level by Integrating an Innovative Ultrasound Program and Curriculum
BOTHELL, WA – August 11, 2010 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the University of California, Irvine, announced today that the company and institution have signed an agreement to integrate ultrasound visualization into UC Irvine’s four-year medical school curriculum.
Under the terms of this agreement, SonoSite will act as an exclusive ultrasound partner. The collaborative efforts of both UC Irvine and SonoSite will provide medical students with an active and dynamic learning experience that will transform traditional teaching methods used during medical school training. SonoSite’s ultrasound systems will enable students to view anatomical structures in real-time and better understand physiological processes. This innovative ultrasound curriculum is setting the standard for other leading medical institutions and providing UC Irvine’s students with the skill set and tools to improve medicine.
“Ultrasound visualization tools are transforming medicine and we are excited to partner with SonoSite and pursue the mission of transforming physical diagnosis,” said Ralph V. Clayman, MD, Dean of the UC Irvine School of Medicine. “It is imperative that we embrace the evolving digital age and provide students with the ability to become well versed in the latest visualization technology, which will ultimately enable them to better diagnose patients. With full institutional support across core faculty and administration, our relationship with SonoSite clearly demonstrates our commitment to providing our students with the tools they need to enhance their learning experience and better prepare them for 21st century medicine.”
“With the power of ultrasound based visual medicine, students will have a learning experience that was unimaginable until now,” said Kevin M. Goodwin, SonoSite President and CEO. “UC Irvine is a very progressive institution and we are excited to participate in this innovative curriculum for their medical school students. UC Irvine and SonoSite have a shared vision to improve medical education and ultimately make an impact on healthcare delivery.”
“By integrating ultrasound into our curriculum, we are giving students the tools they need to practice modern medicine,” said J. Christian Fox, MD, UC Irvine, Director of Instructional Ultrasound “This curriculum is teaching for the future. Sitting in a classroom is passive learning. Reading from a textbook is passive. When you provide students with the opportunity to actually see the anatomy, that’s how they will really learn. Students will be able to directly visualize almost any organ, blood vessel, bone, muscle, or tissue in the body. By the end of their four-year medical training, these students’ ability to diagnose disease will be unsurpassed by any conventional means of practicing medicine.”
“In advance of their residency, this visual learning experience will provide medical students with the knowledge and training to diagnose a myriad of pathologies, increase their proficiency and be armed with the confidence of ultrasound visualization,” said Diku Mandavia, MD, SonoSite’s Senior Vice President and Chief Medical Officer. “Medical students will be able to understand the human body on a whole new level and appreciate the anatomy and physiology, which will be an important framework for their future clinical decisions.”
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
About the UC Irvine School of Medicine
Ranked as one of the top 50 U.S. medical schools for research by U.S. News & World Report, UC Irvines School of Medicine (www.som.uci.edu) is dedicated to advancing medical knowledge and clinical practice through scholarly research, physician education and high-quality care. The medical school nurtures the development of medical students, resident physicians and scholars in the clinical and basic sciences and supports the dissemination of research advances for the benefit of society.
Careers | Site Map | Newsletter | News | Regulatory/Compliance | Privacy | Terms of Use
©2009–2010 SonoSite, Inc. All rights reserved.
Find us on: